You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 9, September 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence and Brief Communications
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Nonantral Gastric Carcinoids and Hypergastrinemia

CESARE BORDI, MD
Parma, Italy

Arch Surg. 1981;116(9):1238.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—Abrams reported in the ARCHIVES (1980;115:1219-1221) a case of multiple malignant carcinoids of the stomach successfully treated with total gastrectomy. The patient also showed pronounced hypergastrinemia and diffuse hyperplasia of argyrophil cells in the nonantral mucosa of the stomach. Since gastrinsecreting cells of the stomach are strictly confined to the antropyloric region, neither tumor cells nor hyperplastic cells can be expected to represent the source of the patient's hypergastrinemia. However, all evidence indicates that the carcinoids are composed of the so-called enterochromaffin-like (ECL) cells, the most frequent (though functionally unknown) endocrine cell type in the nonantral portion of the stomach.1,2

In the study of a case of ECL cell carcinoid and hyperplasia associated with long-standing gastrojejunostomy,1 my colleagues and I suggested that concomitant high levels of gastrin may stimulate the growth of ECL-cell carcinoids. The hypothesis was based on the following evidence. Gastrin is known . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.